Insys Therapeutics, Inc. Inventory Write-down
Insys Therapeutics, Inc. reported Inventory Write-down of $2.83 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2019-05-13
- Insys Therapeutics, Inc. inventory write-down for the quarter ending 2019-03-31 was $2.83M, a 436.17% increase year-over-year.
- Insys Therapeutics, Inc. inventory write-down for the quarter ending 2018-12-31 was $1.60M.
- Insys Therapeutics, Inc. inventory write-down for the quarter ending 2018-09-30 was $493.00K, a 85.38% decline year-over-year.
- Insys Therapeutics, Inc. inventory write-down for the quarter ending 2018-06-30 was $477.00K, a 44.15% decline year-over-year.
- Insys Therapeutics, Inc. inventory write-down for fiscal 2018 was $3.10M, a 49.97% decline from fiscal 2017.
- Insys Therapeutics, Inc. inventory write-down for fiscal 2017 was $6.19M, a 16.37% decline from fiscal 2016.
- Insys Therapeutics, Inc. inventory write-down for fiscal 2016 was $7.40M.
- Insys Therapeutics, Inc. inventory write-down for fiscal 2015 was -$336.00K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 9 month as first filed | Inventory Write-down 12 month |
|---|---|---|---|---|---|
| 2019-03-31 | $2.83M 10-Q · filed 2019-05-13 | $4.43M derived: sum of 2 quarters · filed 2019-05-13 | $4.92M derived: sum of 3 quarters · filed 2019-05-13 | $5.40M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2018-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $2.09M derived: sum of 2 quarters · filed 2019-03-13 | $2.57M derived: sum of 3 quarters · filed 2019-03-13 | $3.10M 10-K · filed 2019-03-13 | |
| 2018-09-30 | $493.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $970.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.50M 10-Q · filed 2018-11-09 | $1.35M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2018-06-30 | $477.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.00M 10-Q · filed 2018-08-09 | $860.00K derived: sum of 3 quarters · filed 2019-05-13 | $4.23M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2018-03-31 | $528.00K 10-Q · filed 2019-05-13 | $383.00K derived: sum of 2 quarters · filed 2019-05-13 | $3.75M derived: sum of 3 quarters · filed 2019-05-13 | $4.61M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2017-12-31 | -$145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $3.23M derived: sum of 2 quarters · filed 2019-03-13 | $4.08M derived: sum of 3 quarters · filed 2019-03-13 | $6.19M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $4.23M derived: sum of 2 quarters · filed 2018-11-09 | $6.33M 10-Q · filed 2018-11-09 | $5.54M 10-Q · filed 2017-11-03 | $10.48M derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-06-30 | $854.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.96M 10-Q · filed 2018-08-09 | $7.11M derived: sum of 3 quarters · filed 2019-03-13 | $9.72M derived: sum of 4 quarters · filed 2019-03-13 | |
| 2017-03-31 | $2.10M 10-Q · filed 2018-05-10 | $6.26M derived: sum of 2 quarters · filed 2019-03-13 | $8.86M derived: sum of 3 quarters · filed 2019-03-13 | ||
| 2016-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $6.76M derived: sum of 2 quarters · filed 2019-03-13 | $7.40M 10-K · filed 2019-03-13 | ||
| 2016-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $3.24M 10-Q · filed 2017-11-03 | |||
| 2016-06-30 | $638.00K 10-Q · filed 2017-08-07 | ||||
| 2015-12-31 | -$336.00K 10-K · filed 2018-03-12 |